Novozymes A-S Aktie
55,70EUR | 0,54EUR | 0,98% |
WKN DE: A1JP9Y / ISIN: DK0060336014
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 6 185 | 6 527 | 6 781 | 6 756 | 10 582 |
Umsatz pro Mitarbeiter in Mio. EUR | 2,27 | 2,29 | 2,59 | 2,65 | 2,70 |
Bilanz (in Mio. EUR) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 6 911 | 7 823 | 9 241 | 9 462 | 14 015 |
Summe Anlagevermögen | 16 105 | 18 015 | 20 786 | 21 759 | 96 742 |
Summe Aktiva | 21 026 | 25 228 | 28 013 | 28 594 | 120 632 |
Bilanz (in Mio. EUR) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 4 872 | 6 188 | 6 949 | 7 781 | 13 399 |
Summe Fremdkapital | 9 782 | 13 022 | 13 785 | 14 243 | 37 290 |
Summe Eigenkapital | 11 244 | 12 206 | 14 228 | 14 351 | 83 342 |
Summe Passiva | 21 026 | 25 228 | 28 013 | 28 594 | 120 632 |
Adresse
Biologiens Vej 2, 2800 Lyngby | |
Internet | http://www.novonesis.com |
Management
Anders Lund
Chief Operating Officer |
Cees de Jong
Chairman |
Claus Crone Fuglsang
Chief Scientific Officer |
Ester Baiget
President & Chief Executive Officer |
Frederikke Rose Spenner
Director |
Heine Dalsgaard
Non-Independent Director |
Henrik Joerck Nielsen
Executive VP-Strategy & Integration |
Jens Kolind
Senior Vice President |
Kasim Kutay
Non-Independent Director |
Kevin Lane
Independent Director |
Kim Stratton
Independent Director |
Lars Bo Koppler
Director |
Lise Kaae
Independent Director |
Monila Kothari
Independent Director |
Morten Enggaard Rasmussen
Executive VP-People & Stakeholder Relations |
Morten Otto Alexander Sommer
Independent Director |
Preben Nielsen
Director |
Rainer Lehmann
Chief Financial Officer |
Robert Noddeskov Jensen
Director |
Tobias Cornelius Bjorklund
Head-Investor Relations |
Winnie Hojvang Bügel
Head-Legal & General Counsel |